Qube Research & Technologies (QRT)
LFVN icon

Qube Research & Technologies (QRT)’s LifeVantage LFVN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LFVN Stock Details LFVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Buy
+54,146
New +$328K ﹤0.01% 2759
2025
Q2 		– Sell
-55,916
Closed -$815K – 3780
2025
Q1 		$815K Buy
55,916
+10,570
+23% +$199K ﹤0.01% 2348
2024
Q4 		$795K Buy
45,346
+31,084
+218% +$436K ﹤0.01% 2295
2024
Q3 		$172K Buy
14,262
+14,261
+1,426,100% +$118K ﹤0.01% 2633
2024
Q2 		$6 Sell
1
-387
-100% -$2.63K ﹤0.01% 3643
2024
Q1 		$2.35K Sell
388
-355
-48% -$2.24K ﹤0.01% 3982
2023
Q4 		$4.46K Buy
743
+742
+74,200% +$4.9K ﹤0.01% 3728
2023
Q3 		$6 Buy
+1
New +$6 ﹤0.01% 3958

Other funds holding LFVN

CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LFVN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in LifeVantage (LFVN) in Q2 2026: 54,146 shares worth $338K. The stake represents ﹤0.01% of the portfolio and ranks #2759 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in LFVN as recently as Q1 2025.

Qube Research & Technologies (QRT) first reported a position in LFVN in Q3 2023 and has held it in 8 quarters since. The position peaked at $815K in Q1 2025. 88 funds tracked by Wall St. Rank hold LFVN as of Q2 2026.

  • Qube Research & Technologies (QRT) held 54,146 shares of LifeVantage worth $338K as of Q2 2026.
  • LifeVantage was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • LifeVantage made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2759 holding.
  • Qube Research & Technologies (QRT) first reported a position in LifeVantage in Q3 2023 and has held it in 8 quarters since.
  • Qube Research & Technologies (QRT)'s LifeVantage position peaked at $815K in Q1 2025.
  • 88 funds tracked by Wall St. Rank held LifeVantage as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.